New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 13, 2014
08:42 EDTIARTIntegra LifeSciences announces first implantation of Integra Laminoplasty System
Integra LifeSciences announced the first implantation of its Integra Laminoplasty System, in the United States. The system, which is used to treat patients with ossification of the posterior longitudinal ligament, cervical myelopathy and degenerative spinal canal stenosis, was implanted by Douglas Orndorff, M.D., Orthopaedic Spine Surgeon at the Mercy Medical Center in Durango, Colorado.
News For IART From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 3, 2015
09:56 EDTIARTIntegra deal with Tornier a win for both, says Piper Jaffray
Piper Jaffray analyst Matt O'Brien said he views Integra LifeSciences' (IART) acquisition of Tornier's (TRNX) U.S. ankle replacement and silastic toe replacement products as a "win win" for both companies. O'Brien estimates a deal price between $25M-$35M, saying he believes Integra gets a "quality total ankle system at an attractive price," while adding that Tornier clears the last hurdle with the FTC for its Wright Medical (WMGI) deal with the divestiture. O'Brien maintains his Overweight rating and $72 price target on Integra shares.
05:34 EDTIARTIntegra LifeSciences to acquire Salto Talaris, Salto XT from Tornier
Subscribe for More Information
August 26, 2015
07:18 EDTIARTIntegra DFU study results positive in aggregate, says Piper Jaffray
Piper Jaffray analyst Matt O'Brien stated after Integra LifeSciences' DFU data was published that some competitive products have better metrics in certain areas. However, all told, O'Brien views the results positively and expects Integra to have one of the best wound care portfolios in the market once this product is cleared and reimbursed sometime next year, he tells investors in a research note. The analyst kept an Overweight rating and $72 price target on Integra shares, which closed up 39c to $59.25 yesterday.
07:13 EDTIARTIntegra LifeSciences announces online publication of FOUNDER study results
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use